instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Peripartum management of a patient with catecholaminergic polymorphic ventricular tachycardia.
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a potentially lethal cardiac channelopathy characterized by episodes of ventricular tachycardia (VT) during exercise or in stressful situations. As the peripartu... | ESMOLOL HYDROCHLORIDE, FLECAINIDE ACETATE, METOPROLOL | DrugsGivenReaction | CC BY | 32978983 | 16,659,519 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Live birth'. | Peripartum management of a patient with catecholaminergic polymorphic ventricular tachycardia.
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a potentially lethal cardiac channelopathy characterized by episodes of ventricular tachycardia (VT) during exercise or in stressful situations. As the peripartu... | ESMOLOL HYDROCHLORIDE, FLECAINIDE ACETATE, METOPROLOL | DrugsGivenReaction | CC BY | 32978983 | 16,659,519 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Peripartum management of a patient with catecholaminergic polymorphic ventricular tachycardia.
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a potentially lethal cardiac channelopathy characterized by episodes of ventricular tachycardia (VT) during exercise or in stressful situations. As the peripartu... | ESMOLOL HYDROCHLORIDE, FLECAINIDE ACETATE, METOPROLOL | DrugsGivenReaction | CC BY | 32978983 | 16,659,519 | 2021-03 |
What was the administration route of drug 'PALBOCICLIB'? | Safety of palbociclib concurrent with palliative pelvic radiotherapy: discussion of a case of increased toxicity and brief review of literature.
Several cyclin-dependent kinase 4/6 (CDK4/6) inhibitors are indicated in the treatment of metastatic hormone receptor-positive (HR)/ human epidermal growth factor receptor 2 (... | Oral | DrugAdministrationRoute | CC BY | 32985794 | 19,170,004 | 2021-03 |
What was the outcome of reaction 'Colitis'? | Safety of palbociclib concurrent with palliative pelvic radiotherapy: discussion of a case of increased toxicity and brief review of literature.
Several cyclin-dependent kinase 4/6 (CDK4/6) inhibitors are indicated in the treatment of metastatic hormone receptor-positive (HR)/ human epidermal growth factor receptor 2 (... | Recovered | ReactionOutcome | CC BY | 32985794 | 19,170,004 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | BETAMETHASONE, ECULIZUMAB, FERROUS FUMARATE, FOLIC ACID, MECLIZINE\PYRIDOXINE, MESALAMINE, METOCLOPRAMIDE, NADROPARIN, NIFEDIPINE, POLYETHYLENE GLYCOLS | DrugsGivenReaction | CC BY-NC | 32986871 | 19,592,741 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoglycaemia'. | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | BETAMETHASONE, ECULIZUMAB, FERROUS FUMARATE, FOLIC ACID, MECLIZINE\PYRIDOXINE, MESALAMINE, METOCLOPRAMIDE, NADROPARIN, NIFEDIPINE, POLYETHYLENE GLYCOLS | DrugsGivenReaction | CC BY-NC | 32986871 | 19,592,738 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature delivery'. | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | BETAMETHASONE, ECULIZUMAB, FERROUS FUMARATE, FOLIC ACID, MECLIZINE\PYRIDOXINE, MESALAMINE, METOCLOPRAMIDE, NADROPARIN, NIFEDIPINE, POLYETHYLENE GLYCOLS | DrugsGivenReaction | CC BY-NC | 32986871 | 19,592,741 | 2021-04 |
What was the administration route of drug 'BETAMETHASONE'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | Transplacental | DrugAdministrationRoute | CC BY-NC | 32986871 | 19,592,738 | 2021-04 |
What was the administration route of drug 'ECULIZUMAB'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | Transplacental | DrugAdministrationRoute | CC BY-NC | 32986871 | 19,592,738 | 2021-04 |
What was the administration route of drug 'FERROUS FUMARATE'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | Transplacental | DrugAdministrationRoute | CC BY-NC | 32986871 | 19,592,738 | 2021-04 |
What was the administration route of drug 'FOLIC ACID'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | Transplacental | DrugAdministrationRoute | CC BY-NC | 32986871 | 19,592,738 | 2021-04 |
What was the administration route of drug 'MECLIZINE HYDROCHLORIDE'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | Transplacental | DrugAdministrationRoute | CC BY-NC | 32986871 | 18,480,112 | 2021-04 |
What was the administration route of drug 'MECLIZINE\PYRIDOXINE'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | Transplacental | DrugAdministrationRoute | CC BY-NC | 32986871 | 19,592,738 | 2021-04 |
What was the administration route of drug 'MESALAMINE'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | Transplacental | DrugAdministrationRoute | CC BY-NC | 32986871 | 19,592,738 | 2021-04 |
What was the administration route of drug 'METOCLOPRAMIDE'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | Transplacental | DrugAdministrationRoute | CC BY-NC | 32986871 | 19,592,738 | 2021-04 |
What was the administration route of drug 'NADROPARIN'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | Transplacental | DrugAdministrationRoute | CC BY-NC | 32986871 | 19,592,738 | 2021-04 |
What was the administration route of drug 'NIFEDIPINE'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | Transplacental | DrugAdministrationRoute | CC BY-NC | 32986871 | 19,592,738 | 2021-04 |
What was the administration route of drug 'POLYETHYLENE GLYCOLS'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | Transplacental | DrugAdministrationRoute | CC BY-NC | 32986871 | 19,592,738 | 2021-04 |
What was the dosage of drug 'BETAMETHASONE'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | MATERNAL DOSE: UNK | DrugDosageText | CC BY-NC | 32986871 | 18,480,112 | 2021-04 |
What was the dosage of drug 'FERROUS FUMARATE'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | MATERNAL DOSE: UNK | DrugDosageText | CC BY-NC | 32986871 | 18,480,112 | 2021-04 |
What was the dosage of drug 'FOLIC ACID'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | MATERNAL DOSE: UNK | DrugDosageText | CC BY-NC | 32986871 | 18,480,112 | 2021-04 |
What was the dosage of drug 'MECLIZINE HYDROCHLORIDE'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | MATERNAL DOSE: UNK | DrugDosageText | CC BY-NC | 32986871 | 18,480,112 | 2021-04 |
What was the dosage of drug 'MESALAMINE'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | MATERNAL DOSE: UNK | DrugDosageText | CC BY-NC | 32986871 | 18,480,112 | 2021-04 |
What was the dosage of drug 'METOCLOPRAMIDE'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | MATERNAL DOSE: UNK | DrugDosageText | CC BY-NC | 32986871 | 18,480,112 | 2021-04 |
What was the dosage of drug 'NADROPARIN'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | MATERNAL DOSE: UNK | DrugDosageText | CC BY-NC | 32986871 | 18,480,112 | 2021-04 |
What was the dosage of drug 'NIFEDIPINE'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | MATERNAL DOSE: UNK | DrugDosageText | CC BY-NC | 32986871 | 18,480,112 | 2021-04 |
What was the dosage of drug 'POLYETHYLENE GLYCOLS'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | MATERNAL DOSE: UNK | DrugDosageText | CC BY-NC | 32986871 | 18,480,112 | 2021-04 |
What was the outcome of reaction 'Hypoglycaemia neonatal'? | Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria.
Eculizumab is known to cross the placenta to a limited degree, but recently therapeutic drug levels in cord blood were found in a single case. We report maternal, cord and placental levels ... | Recovered | ReactionOutcome | CC BY-NC | 32986871 | 19,541,122 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | The efficacy of the submucosal injection of lidocaine during endoscopic submucosal dissection for colorectal neoplasms: a multicenter randomized controlled study.
Endoscopic submucosal dissection (ESD) is currently a common procedure although it requires a long procedural time. We conducted a prospective study to deter... | LIDOCAINE | DrugsGivenReaction | CC BY | 32989543 | 20,768,331 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | Findings of Hepatic Severe Acute Respiratory Syndrome Coronavirus-2 Infection.
Liver injury due to coronavirus disease 2019 (COVID-19) is being increasingly recognized. Abnormal liver chemistry tests of varying severities occur in a majority of patients. However, there is a dearth of accompanying liver histologic studi... | TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 32992052 | 19,840,647 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic kidney disease'. | Findings of Hepatic Severe Acute Respiratory Syndrome Coronavirus-2 Infection.
Liver injury due to coronavirus disease 2019 (COVID-19) is being increasingly recognized. Abnormal liver chemistry tests of varying severities occur in a majority of patients. However, there is a dearth of accompanying liver histologic studi... | TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 32992052 | 19,840,647 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephropathy toxic'. | Findings of Hepatic Severe Acute Respiratory Syndrome Coronavirus-2 Infection.
Liver injury due to coronavirus disease 2019 (COVID-19) is being increasingly recognized. Abnormal liver chemistry tests of varying severities occur in a majority of patients. However, there is a dearth of accompanying liver histologic studi... | TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 32992052 | 19,840,647 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Severe acute respiratory syndrome'. | Findings of Hepatic Severe Acute Respiratory Syndrome Coronavirus-2 Infection.
Liver injury due to coronavirus disease 2019 (COVID-19) is being increasingly recognized. Abnormal liver chemistry tests of varying severities occur in a majority of patients. However, there is a dearth of accompanying liver histologic studi... | TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 32992052 | 19,840,647 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Contrast encephalopathy'. | Low-dose Contrast-induced Encephalopathy During Diagnostic Cerebral Angiography.
Contrast-induced encephalopathy (CIE) is a rare complication of contrast agent use. We herein report a case of acute lacunar infarction in a 70-year-old woman. During diagnostic cerebral angiography for asymptomatic common carotid stenosis... | IOPAMIDOL | DrugsGivenReaction | CC BY-NC-ND | 32999223 | 19,725,577 | 2021-02-15 |
What was the dosage of drug 'IOPAMIDOL'? | Low-dose Contrast-induced Encephalopathy During Diagnostic Cerebral Angiography.
Contrast-induced encephalopathy (CIE) is a rare complication of contrast agent use. We herein report a case of acute lacunar infarction in a 70-year-old woman. During diagnostic cerebral angiography for asymptomatic common carotid stenosis... | 43 ML, SINGLE | DrugDosageText | CC BY-NC-ND | 32999223 | 19,725,577 | 2021-02-15 |
What was the outcome of reaction 'Contrast encephalopathy'? | Low-dose Contrast-induced Encephalopathy During Diagnostic Cerebral Angiography.
Contrast-induced encephalopathy (CIE) is a rare complication of contrast agent use. We herein report a case of acute lacunar infarction in a 70-year-old woman. During diagnostic cerebral angiography for asymptomatic common carotid stenosis... | Recovered | ReactionOutcome | CC BY-NC-ND | 32999223 | 19,725,577 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Left ventricular dysfunction'. | An Irreversible Worsening Cardiac Function after Withdrawing Medical Treatments in a Patient with Dilated Cardiomyopathy: A Pathological Analysis.
A 44-year-old man diagnosed with idiopathic dilated cardiomyopathy was admitted to our hospital with acute decompensated heart failure. Seven years before this admission, th... | CARVEDILOL, PERINDOPRIL, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC-ND | 32999224 | 19,844,191 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocardial fibrosis'. | An Irreversible Worsening Cardiac Function after Withdrawing Medical Treatments in a Patient with Dilated Cardiomyopathy: A Pathological Analysis.
A 44-year-old man diagnosed with idiopathic dilated cardiomyopathy was admitted to our hospital with acute decompensated heart failure. Seven years before this admission, th... | CARVEDILOL, PERINDOPRIL, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC-ND | 32999224 | 19,844,191 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Withdrawal syndrome'. | An Irreversible Worsening Cardiac Function after Withdrawing Medical Treatments in a Patient with Dilated Cardiomyopathy: A Pathological Analysis.
A 44-year-old man diagnosed with idiopathic dilated cardiomyopathy was admitted to our hospital with acute decompensated heart failure. Seven years before this admission, th... | CARVEDILOL, PERINDOPRIL, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC-ND | 32999224 | 19,844,191 | 2021-02-15 |
What was the outcome of reaction 'Left ventricular dysfunction'? | An Irreversible Worsening Cardiac Function after Withdrawing Medical Treatments in a Patient with Dilated Cardiomyopathy: A Pathological Analysis.
A 44-year-old man diagnosed with idiopathic dilated cardiomyopathy was admitted to our hospital with acute decompensated heart failure. Seven years before this admission, th... | Fatal | ReactionOutcome | CC BY-NC-ND | 32999224 | 19,844,191 | 2021-02-15 |
What was the outcome of reaction 'Myocardial fibrosis'? | An Irreversible Worsening Cardiac Function after Withdrawing Medical Treatments in a Patient with Dilated Cardiomyopathy: A Pathological Analysis.
A 44-year-old man diagnosed with idiopathic dilated cardiomyopathy was admitted to our hospital with acute decompensated heart failure. Seven years before this admission, th... | Fatal | ReactionOutcome | CC BY-NC-ND | 32999224 | 19,844,191 | 2021-02-15 |
What was the outcome of reaction 'Withdrawal syndrome'? | An Irreversible Worsening Cardiac Function after Withdrawing Medical Treatments in a Patient with Dilated Cardiomyopathy: A Pathological Analysis.
A 44-year-old man diagnosed with idiopathic dilated cardiomyopathy was admitted to our hospital with acute decompensated heart failure. Seven years before this admission, th... | Fatal | ReactionOutcome | CC BY-NC-ND | 32999224 | 19,844,191 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperglycaemia'. | The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia.
Novel treatments with rituximab or direct-acting antiviral agents (DAAs) were expected to impro... | METHYLPREDNISOLONE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 32999232 | 19,870,219 | 2021-02-15 |
What is the weight of the patient? | The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia.
Novel treatments with rituximab or direct-acting antiviral agents (DAAs) were expected to impro... | 61.7 kg. | Weight | CC BY-NC-ND | 32999232 | 19,870,219 | 2021-02-15 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia.
Novel treatments with rituximab or direct-acting antiviral agents (DAAs) were expected to impro... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 32999232 | 19,870,219 | 2021-02-15 |
What was the administration route of drug 'PREDNISOLONE'? | The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia.
Novel treatments with rituximab or direct-acting antiviral agents (DAAs) were expected to impro... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 32999232 | 19,870,219 | 2021-02-15 |
What was the outcome of reaction 'Hyperglycaemia'? | The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia.
Novel treatments with rituximab or direct-acting antiviral agents (DAAs) were expected to impro... | Recovered | ReactionOutcome | CC BY-NC-ND | 32999232 | 19,870,219 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abortion spontaneous'. | Anti-glomerular Basement Membrane Glomerulonephritis During the First Trimester of Pregnancy.
A 28-year-old woman was admitted during the eighth week of her pregnancy because her clinical course was consistent with rapid progressive glomerulonephritis (RPGN). Anti-glomerular basement membrane antibody (anti-GBM Ab) and... | AMOXICILLIN, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 32999239 | 19,271,789 | 2021-03-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Anti-glomerular Basement Membrane Glomerulonephritis During the First Trimester of Pregnancy.
A 28-year-old woman was admitted during the eighth week of her pregnancy because her clinical course was consistent with rapid progressive glomerulonephritis (RPGN). Anti-glomerular basement membrane antibody (anti-GBM Ab) and... | AMOXICILLIN, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 32999239 | 19,271,789 | 2021-03-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Compromised barrier integrity of human feto-placental vessels from gestational diabetic pregnancies is related to downregulation of occludin expression.
Reduced occupancy of junctional occludin is a feature of human placental vessels in the diabetic milieu. However, the functional consequence of this and whether this l... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33001231 | 18,647,408 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Papilloedema'. | Growth Hormone Treatment and Papilledema: A Prospective Pilot Study
To investigate the incidence of pseudotumor cerebri syndrome (PTCS) in children treated with growth hormone (GH) in a paediatric hospital and to identify risk factors for this complication.
Prospective pilot study of paediatric patients treated with... | SOMATROPIN | DrugsGivenReaction | CC BY-NC-ND | 33006547 | 19,423,694 | 2021-06-02 |
What was the outcome of reaction 'Papilloedema'? | Growth Hormone Treatment and Papilledema: A Prospective Pilot Study
To investigate the incidence of pseudotumor cerebri syndrome (PTCS) in children treated with growth hormone (GH) in a paediatric hospital and to identify risk factors for this complication.
Prospective pilot study of paediatric patients treated with... | Recovered | ReactionOutcome | CC BY-NC-ND | 33006547 | 19,423,694 | 2021-06-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal haemorrhage'. | A case of tuberculosis meningitis after allogeneic hematopoietic stem cell transplantation for relapsed Acute Myeloid Leukemia.
We report a case of tuberculosis (TB) meningitis after allogeneic hematopoietic stem cell transplantation (HSCT) for relapsed acute myeloid leukemia. The patient was 52-year-old woman who had ... | AMIKACIN, AMOXICILLIN\CLAVULANIC ACID, CYCLOSERINE, DEXAMETHASONE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LINEZOLID, MANNITOL, MEROPENEM, MOXIFLOXACIN, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, RIFAMPIN, VANCOMYCIN | DrugsGivenReaction | CC BY | 33012077 | 19,514,344 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancytopenia'. | A case of tuberculosis meningitis after allogeneic hematopoietic stem cell transplantation for relapsed Acute Myeloid Leukemia.
We report a case of tuberculosis (TB) meningitis after allogeneic hematopoietic stem cell transplantation (HSCT) for relapsed acute myeloid leukemia. The patient was 52-year-old woman who had ... | AMIKACIN, AMOXICILLIN\CLAVULANIC ACID, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LINEZOLID, MEROPENEM, MOXIFLOXACIN, RIFAMPIN | DrugsGivenReaction | CC BY | 33012077 | 19,606,016 | 2021-04 |
What was the administration route of drug 'AMIKACIN'? | A case of tuberculosis meningitis after allogeneic hematopoietic stem cell transplantation for relapsed Acute Myeloid Leukemia.
We report a case of tuberculosis (TB) meningitis after allogeneic hematopoietic stem cell transplantation (HSCT) for relapsed acute myeloid leukemia. The patient was 52-year-old woman who had ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33012077 | 19,514,344 | 2021-04 |
What was the administration route of drug 'ETHAMBUTOL HYDROCHLORIDE'? | A case of tuberculosis meningitis after allogeneic hematopoietic stem cell transplantation for relapsed Acute Myeloid Leukemia.
We report a case of tuberculosis (TB) meningitis after allogeneic hematopoietic stem cell transplantation (HSCT) for relapsed acute myeloid leukemia. The patient was 52-year-old woman who had ... | Oral | DrugAdministrationRoute | CC BY | 33012077 | 19,514,344 | 2021-04 |
What was the administration route of drug 'ISONIAZID'? | A case of tuberculosis meningitis after allogeneic hematopoietic stem cell transplantation for relapsed Acute Myeloid Leukemia.
We report a case of tuberculosis (TB) meningitis after allogeneic hematopoietic stem cell transplantation (HSCT) for relapsed acute myeloid leukemia. The patient was 52-year-old woman who had ... | Oral | DrugAdministrationRoute | CC BY | 33012077 | 19,514,344 | 2021-04 |
What was the administration route of drug 'LINEZOLID'? | A case of tuberculosis meningitis after allogeneic hematopoietic stem cell transplantation for relapsed Acute Myeloid Leukemia.
We report a case of tuberculosis (TB) meningitis after allogeneic hematopoietic stem cell transplantation (HSCT) for relapsed acute myeloid leukemia. The patient was 52-year-old woman who had ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33012077 | 19,514,344 | 2021-04 |
What was the administration route of drug 'MOXIFLOXACIN'? | A case of tuberculosis meningitis after allogeneic hematopoietic stem cell transplantation for relapsed Acute Myeloid Leukemia.
We report a case of tuberculosis (TB) meningitis after allogeneic hematopoietic stem cell transplantation (HSCT) for relapsed acute myeloid leukemia. The patient was 52-year-old woman who had ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33012077 | 19,514,344 | 2021-04 |
What was the outcome of reaction 'Gastrointestinal haemorrhage'? | A case of tuberculosis meningitis after allogeneic hematopoietic stem cell transplantation for relapsed Acute Myeloid Leukemia.
We report a case of tuberculosis (TB) meningitis after allogeneic hematopoietic stem cell transplantation (HSCT) for relapsed acute myeloid leukemia. The patient was 52-year-old woman who had ... | Recovered | ReactionOutcome | CC BY | 33012077 | 19,514,344 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cholangitis acute'. | Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.
An 82-year-old man with hepatocellular carcinoma presented with upper abdominal pain, vomiting, and jaundice. He had been taking a standard lenvatinib dose for three months. Although acute cholangitis was suggested, i... | ASPIRIN, LENVATINIB, RABEPRAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33028766 | 18,412,747 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Duodenal ulcer'. | Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.
An 82-year-old man with hepatocellular carcinoma presented with upper abdominal pain, vomiting, and jaundice. He had been taking a standard lenvatinib dose for three months. Although acute cholangitis was suggested, i... | ASPIRIN, LENVATINIB, RABEPRAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33028766 | 18,412,747 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Enterobacter bacteraemia'. | Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.
An 82-year-old man with hepatocellular carcinoma presented with upper abdominal pain, vomiting, and jaundice. He had been taking a standard lenvatinib dose for three months. Although acute cholangitis was suggested, i... | ASPIRIN, LENVATINIB, RABEPRAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33028766 | 18,412,747 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Impaired healing'. | Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.
An 82-year-old man with hepatocellular carcinoma presented with upper abdominal pain, vomiting, and jaundice. He had been taking a standard lenvatinib dose for three months. Although acute cholangitis was suggested, i... | ASPIRIN, LENVATINIB, RABEPRAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33028766 | 18,412,747 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Jaundice cholestatic'. | Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.
An 82-year-old man with hepatocellular carcinoma presented with upper abdominal pain, vomiting, and jaundice. He had been taking a standard lenvatinib dose for three months. Although acute cholangitis was suggested, i... | ASPIRIN, LENVATINIB, RABEPRAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33028766 | 18,412,747 | 2021-02-15 |
What is the weight of the patient? | Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.
An 82-year-old man with hepatocellular carcinoma presented with upper abdominal pain, vomiting, and jaundice. He had been taking a standard lenvatinib dose for three months. Although acute cholangitis was suggested, i... | 59 kg. | Weight | CC BY-NC-ND | 33028766 | 18,412,747 | 2021-02-15 |
What was the administration route of drug 'LENVATINIB'? | Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.
An 82-year-old man with hepatocellular carcinoma presented with upper abdominal pain, vomiting, and jaundice. He had been taking a standard lenvatinib dose for three months. Although acute cholangitis was suggested, i... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33028766 | 18,412,747 | 2021-02-15 |
What was the administration route of drug 'RABEPRAZOLE'? | Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.
An 82-year-old man with hepatocellular carcinoma presented with upper abdominal pain, vomiting, and jaundice. He had been taking a standard lenvatinib dose for three months. Although acute cholangitis was suggested, i... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33028766 | 18,412,747 | 2021-02-15 |
What was the dosage of drug 'ASPIRIN'? | Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.
An 82-year-old man with hepatocellular carcinoma presented with upper abdominal pain, vomiting, and jaundice. He had been taking a standard lenvatinib dose for three months. Although acute cholangitis was suggested, i... | DOSE AND FREQUENCY NOT PROVIDED | DrugDosageText | CC BY-NC-ND | 33028766 | 18,412,747 | 2021-02-15 |
What was the dosage of drug 'LENVATINIB'? | Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.
An 82-year-old man with hepatocellular carcinoma presented with upper abdominal pain, vomiting, and jaundice. He had been taking a standard lenvatinib dose for three months. Although acute cholangitis was suggested, i... | 8 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33028766 | 18,412,747 | 2021-02-15 |
What was the dosage of drug 'RABEPRAZOLE'? | Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.
An 82-year-old man with hepatocellular carcinoma presented with upper abdominal pain, vomiting, and jaundice. He had been taking a standard lenvatinib dose for three months. Although acute cholangitis was suggested, i... | DOSE AND FREQUENCY NOT PROVIDED | DrugDosageText | CC BY-NC-ND | 33028766 | 18,412,747 | 2021-02-15 |
What was the outcome of reaction 'Duodenal ulcer'? | Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.
An 82-year-old man with hepatocellular carcinoma presented with upper abdominal pain, vomiting, and jaundice. He had been taking a standard lenvatinib dose for three months. Although acute cholangitis was suggested, i... | Recovered | ReactionOutcome | CC BY-NC-ND | 33028766 | 18,412,747 | 2021-02-15 |
What was the outcome of reaction 'Enterobacter bacteraemia'? | Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.
An 82-year-old man with hepatocellular carcinoma presented with upper abdominal pain, vomiting, and jaundice. He had been taking a standard lenvatinib dose for three months. Although acute cholangitis was suggested, i... | Recovering | ReactionOutcome | CC BY-NC-ND | 33028766 | 18,412,747 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lung squamous cell carcinoma stage I'. | Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis.
A 72-year-old man was treated with prednisolone and cyclosporine A for idiopathic pulmonary fibrosis. A nodule with a diameter of 19 mm was found in the r... | CYCLOSPORINE, PIRFENIDONE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33028767 | 19,200,217 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis.
A 72-year-old man was treated with prednisolone and cyclosporine A for idiopathic pulmonary fibrosis. A nodule with a diameter of 19 mm was found in the r... | CYCLOSPORINE, PIRFENIDONE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33028767 | 19,200,217 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Intravenous immunoglobulin therapy in COVID-19-related encephalopathy.
OBJECTIVE
To report on efficacy and safety of intravenous immunoglobulin (IVIg) therapy in a case series of patients with COVID-19-related encephalopathy.
METHODS
We retrospectively collected data on all patients with COVID-19 hospitalized at two ... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 33030607 | 20,053,014 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Intravenous immunoglobulin therapy in COVID-19-related encephalopathy.
OBJECTIVE
To report on efficacy and safety of intravenous immunoglobulin (IVIg) therapy in a case series of patients with COVID-19-related encephalopathy.
METHODS
We retrospectively collected data on all patients with COVID-19 hospitalized at two ... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 33030607 | 20,053,014 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaphylactic reaction'. | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | CARBOPLATIN, CETIRIZINE HYDROCHLORIDE, CHLORPHENIRAMINE HYDROCHLORIDE, CROMOLYN SODIUM, DEXAMETHASONE, FEXOFENADINE HYDROCHLORIDE, KETOTIFEN, MONTELUKAST SODIUM, ONDANSETRON, PACLITAXEL, RANITIDINE | DrugsGivenReaction | CC BY | 33032491 | 18,450,575 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Back pain'. | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | CARBOPLATIN, CETIRIZINE HYDROCHLORIDE, CHLORPHENIRAMINE HYDROCHLORIDE, CROMOLYN SODIUM, DEXAMETHASONE, FEXOFENADINE HYDROCHLORIDE, KETOTIFEN, MONTELUKAST SODIUM, ONDANSETRON, PACLITAXEL, RANITIDINE | DrugsGivenReaction | CC BY | 33032491 | 18,450,575 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | CARBOPLATIN, CETIRIZINE HYDROCHLORIDE, CHLORPHENIRAMINE HYDROCHLORIDE, CROMOLYN SODIUM, DEXAMETHASONE, FEXOFENADINE HYDROCHLORIDE, KETOTIFEN, MONTELUKAST SODIUM, ONDANSETRON, PACLITAXEL, RANITIDINE | DrugsGivenReaction | CC BY | 33032491 | 18,450,575 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dry skin'. | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | CARBOPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY | 33032491 | 18,523,491 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | CARBOPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY | 33032491 | 18,523,491 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Flushing'. | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | CARBOPLATIN, CETIRIZINE HYDROCHLORIDE, CHLORPHENIRAMINE HYDROCHLORIDE, CROMOLYN SODIUM, DEXAMETHASONE, FEXOFENADINE HYDROCHLORIDE, KETOTIFEN, MONTELUKAST SODIUM, ONDANSETRON, PACLITAXEL, RANITIDINE | DrugsGivenReaction | CC BY | 33032491 | 18,450,575 | 2021-06 |
What was the administration route of drug 'CARBOPLATIN'? | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33032491 | 18,450,575 | 2021-06 |
What was the administration route of drug 'CETIRIZINE HYDROCHLORIDE'? | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | Oral | DrugAdministrationRoute | CC BY | 33032491 | 18,450,575 | 2021-06 |
What was the administration route of drug 'CHLORPHENIRAMINE HYDROCHLORIDE'? | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33032491 | 18,450,575 | 2021-06 |
What was the administration route of drug 'ONDANSETRON'? | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33032491 | 18,450,575 | 2021-06 |
What was the administration route of drug 'PACLITAXEL'? | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33032491 | 18,450,575 | 2021-06 |
What was the dosage of drug 'CETIRIZINE HYDROCHLORIDE'? | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | 10 MILLIGRAM, CYCLE 1, 2, 3 + 4 | DrugDosageText | CC BY | 33032491 | 18,450,575 | 2021-06 |
What was the dosage of drug 'CHLORPHENIRAMINE HYDROCHLORIDE'? | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | 10 MG, CYCLE 1, 2, 3, 4 (30 MIN BEFORE) | DrugDosageText | CC BY | 33032491 | 18,450,575 | 2021-06 |
What was the dosage of drug 'ONDANSETRON'? | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | 8 MG, CYCLE 1, 2, 3 + 4 (30 MIN BEFORE) | DrugDosageText | CC BY | 33032491 | 18,450,575 | 2021-06 |
What was the outcome of reaction 'Back pain'? | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | Recovered | ReactionOutcome | CC BY | 33032491 | 18,450,575 | 2021-06 |
What was the outcome of reaction 'Dry skin'? | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | Recovered | ReactionOutcome | CC BY | 33032491 | 18,523,491 | 2021-06 |
What was the outcome of reaction 'Fatigue'? | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | Recovered | ReactionOutcome | CC BY | 33032491 | 18,523,491 | 2021-06 |
What was the outcome of reaction 'Flushing'? | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | Recovered | ReactionOutcome | CC BY | 33032491 | 18,450,575 | 2021-06 |
What was the outcome of reaction 'Hypersensitivity'? | Safe administration of chemotherapy in mast cell activation syndrome.
BACKGROUND
Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis... | Recovered | ReactionOutcome | CC BY | 33032491 | 18,450,575 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Development of donepezil-induced hypokalemia following treatment of cognitive impairment.
Donepezil is a cholinesterase inhibitor used extensively to treat Alzheimer disease. The increased cholinergic activity is associated with adverse effects, therefore gastrointestinal symptoms, including nausea, vomiting, and diarr... | CHOLINE ALFOSCERATE, DONEPEZIL | DrugsGivenReaction | CC BY-NC | 33045804 | 18,742,345 | 2021-01 |
What was the administration route of drug 'DONEPEZIL'? | Development of donepezil-induced hypokalemia following treatment of cognitive impairment.
Donepezil is a cholinesterase inhibitor used extensively to treat Alzheimer disease. The increased cholinergic activity is associated with adverse effects, therefore gastrointestinal symptoms, including nausea, vomiting, and diarr... | Oral | DrugAdministrationRoute | CC BY-NC | 33045804 | 18,742,345 | 2021-01 |
What was the dosage of drug 'CHOLINE ALFOSCERATE'? | Development of donepezil-induced hypokalemia following treatment of cognitive impairment.
Donepezil is a cholinesterase inhibitor used extensively to treat Alzheimer disease. The increased cholinergic activity is associated with adverse effects, therefore gastrointestinal symptoms, including nausea, vomiting, and diarr... | 400 mg (milligrams). | DrugDosage | CC BY-NC | 33045804 | 18,430,605 | 2021-01 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.